In PD models in rats, apocynin, a nonspecific NOX inhibitor, was capable of preventing alpha-synuclein aggregation as well as alpha-synuclein mediated NOX activation and ROS production (Sharma et al., 2016). The gene discussed is SNCA; the disease is Parkinson disease.